QuorumCivic. Hidden in plain sight Get the app
Bill intelligence
Full Simple

Congress funds research into a serious menstrual problem.

H.R. 8160 — Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 · Filed by Yassamin Ansari (D-AZ) · 29 cosponsors · Introduced Mar 30, 2026 · Referred to committee

92%
How clear the bill is
Typical bill: 85%
8/100
Chance of hidden extras
Typical bill: 15/100
Public Health Research and Education

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill tells the government to spend money on research about PMDD. PMDD is a severe problem that affects 5 to 8 percent of women. The bill pays for research and teaches doctors and nurses about PMDD. It also tells the public about the problem. The money would be spent from 2026 to 2031.

Who it affects

Women and people assigned female at birth with PMDD would get better ways to find and treat it. Medical schools, nursing schools, and research centers would get money to train doctors and nurses.

One thing to notice

The bill does not say how much money will be spent. Congress will make that choice later.

From the analysis of the bill text, linked under Primary records below.

Where it stands

29 cosponsors: 29 Democrats.

  • Mar 30, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Mar 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 groups reported lobbying about this bill. They filed 1 reports from Jun 2026 to Jun 2026.

Those reports show $96,000 in lobbying spending. Each report lists about 31 bills. So that money was not all for this bill.

More groups named this bill than 0% of bills with any report.

Yassamin Ansari, who sponsored the bill, received $239,033 from PACs for the 2026 election.

  • American College of Obstetricians and Gynecologists — $96,000 in 1 report

Lobbying is legal. These reports show who lobbied about this bill, not what changed.

Words to know

  • research — Scientific study to learn more about a health problem and how to treat it.
  • lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
  • PACs — Groups that collect money and give it to candidates for office.
  • sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (5,860 characters) on Apr 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,778 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Jul 20, 2026 · page rendered 2026-11-02.

“Congress funds research into a serious menstrual problem.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8160/simple Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.